Elizabeth R. Macari

676 total citations
15 papers, 434 citations indexed

About

Elizabeth R. Macari is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Elizabeth R. Macari has authored 15 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Physiology. Recurrent topics in Elizabeth R. Macari's work include Hemoglobinopathies and Related Disorders (6 papers), CRISPR and Genetic Engineering (4 papers) and Virus-based gene therapy research (4 papers). Elizabeth R. Macari is often cited by papers focused on Hemoglobinopathies and Related Disorders (6 papers), CRISPR and Genetic Engineering (4 papers) and Virus-based gene therapy research (4 papers). Elizabeth R. Macari collaborates with scholars based in United States, Sweden and Czechia. Elizabeth R. Macari's co-authors include Christopher H. Lowrey, Driss Zoukhri, Claire L. Kublin, Chelsea D. Boyd, Rodwell Mabaera, Emily K. Schaeffer, Sun Choi, Alison M. Taylor, Leonard I. Zon and Blanche P. Alter and has published in prestigious journals such as Blood, Journal of Neurochemistry and Virology.

In The Last Decade

Elizabeth R. Macari

14 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth R. Macari United States 8 217 174 105 83 79 15 434
Nicola Cogan United Kingdom 8 168 0.8× 86 0.5× 96 0.9× 255 3.1× 57 0.7× 11 446
Virginie Salnot France 7 128 0.6× 42 0.2× 48 0.5× 117 1.4× 44 0.6× 15 285
MJ Tanner United Kingdom 8 149 0.7× 59 0.3× 192 1.8× 329 4.0× 35 0.4× 16 502
Crystal Sung United States 11 102 0.5× 23 0.1× 36 0.3× 226 2.7× 51 0.6× 16 432
Nashmil Emami Canada 9 139 0.6× 173 1.0× 86 0.8× 30 0.4× 32 0.4× 10 397
Tomohito Yagi Japan 11 137 0.6× 28 0.2× 204 1.9× 22 0.3× 177 2.2× 14 514
B P Alter United States 7 235 1.1× 135 0.8× 222 2.1× 56 0.7× 33 0.4× 10 400
Petra Kapaun Germany 7 73 0.3× 45 0.3× 92 0.9× 157 1.9× 77 1.0× 7 331
Yuxia Zhan United States 12 202 0.9× 70 0.4× 151 1.4× 30 0.4× 10 0.1× 20 425
S. Murphy United States 8 80 0.4× 129 0.7× 121 1.2× 44 0.5× 65 0.8× 13 341

Countries citing papers authored by Elizabeth R. Macari

Since Specialization
Citations

This map shows the geographic impact of Elizabeth R. Macari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth R. Macari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth R. Macari more than expected).

Fields of papers citing papers by Elizabeth R. Macari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth R. Macari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth R. Macari. The network helps show where Elizabeth R. Macari may publish in the future.

Co-authorship network of co-authors of Elizabeth R. Macari

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth R. Macari. A scholar is included among the top collaborators of Elizabeth R. Macari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth R. Macari. Elizabeth R. Macari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Pomeroy, Emily J., Andrew V. Anzalone, Kanut Laoharawee, et al.. (2023). Multiplex Prime Editing and PASSIGE TM for Non-Viral Generation of an Allogeneic CAR-T Cell Product. Blood. 142(Supplement 1). 4803–4803. 7 indexed citations
2.
Walters, Mark C., Alexis A. Thompson, Janet L. Kwiatkowski, et al.. (2022). Lovo-cel (bb1111) Gene Therapy for Sickle Cell Disease: Updated Clinical Results and Investigations into Two Cases of Anemia from Group C of the Phase 1/2 HGB-206 Study. Blood. 140(Supplement 1). 26–28. 4 indexed citations
3.
Bonner, Melissa, Julie Kanter, Elizabeth R. Macari, et al.. (2019). The Relationships between Target Gene Transduction, Engraftment of HSCs and RBC Physiology in Sickle Cell Disease Gene Therapy. Blood. 134(Supplement_1). 206–206. 6 indexed citations
4.
Macari, Elizabeth R., Alison M. Taylor, David M. Raiser, et al.. (2016). Calmodulin Inhibition Rescues DBA Models with Ribosomal Protein Deficiency through Reduction of RSK Signaling. Blood. 128(22). 332–332. 9 indexed citations
5.
Doulatov, Sergei, Linda T. Vo, Elizabeth R. Macari, et al.. (2016). Drug discovery using induced pluripotent stem cells identifies autophagy as a therapeutic pathway for anemia. Experimental Hematology. 44(9). S48–S48. 1 indexed citations
6.
Macari, Elizabeth R., Lea Jessop, Steven R. Ellis, et al.. (2014). Whole-exome sequencing and functional studies identify RPS29 as a novel gene mutated in multicase Diamond-Blackfan anemia families. Blood. 124(1). 24–32. 69 indexed citations
7.
Doulatov, Sergei, Linda T. Vo, Elizabeth R. Macari, et al.. (2014). Modeling Diamond Blackfan Anemia in Vivo Using Human Induced Pluripotent Stem Cells. Blood. 124(21). 359–359. 1 indexed citations
8.
9.
Macari, Elizabeth R. & Christopher H. Lowrey. (2011). Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway. Blood. 117(22). 5987–5997. 71 indexed citations
10.
11.
Macari, Elizabeth R., et al.. (2009). Induction of γ-Globin Gene Expression Via the Nrf2/Antioxidant Response Element Signaling Pathway.. Blood. 114(22). 975–975. 2 indexed citations
12.
Mabaera, Rodwell, et al.. (2008). A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger. Experimental Hematology. 36(9). 1057–1072. 103 indexed citations
13.
Bryant, Kevin F., et al.. (2008). ICP34.5-dependent and -independent activities of salubrinal in herpes simplex virus-1 infected cells. Virology. 379(2). 197–204. 24 indexed citations
14.
Zoukhri, Driss, Elizabeth R. Macari, & Claire L. Kublin. (2007). A single injection of interleukin-1 induces reversible aqueous-tear deficiency, lacrimal gland inflammation, and acinar and ductal cell proliferation. Experimental Eye Research. 84(5). 894–904. 79 indexed citations
15.
Zoukhri, Driss, Elizabeth R. Macari, Sun Choi, & Claire L. Kublin. (2005). c‐Jun NH2‐terminal kinase mediates interleukin‐1β‐induced inhibition of lacrimal gland secretion. Journal of Neurochemistry. 96(1). 126–135. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola Cogan Breakdown of academic impact, for papers by Virginie Salnot Breakdown of academic impact, for papers by MJ Tanner Breakdown of academic impact, for papers by Crystal Sung Breakdown of academic impact, for papers by Nashmil Emami Breakdown of academic impact, for papers by Tomohito Yagi Breakdown of academic impact, for papers by B P Alter Breakdown of academic impact, for papers by Petra Kapaun Breakdown of academic impact, for papers by Yuxia Zhan Breakdown of academic impact, for papers by S. Murphy
Rankless by CCL
2026